GERN Stock Price
Geron Corporation
$0.99
+$0.00(+0.05%)
43
Overall
60
Value
27
Tech
42
Quality
Market Cap
$637.99M
Volume
2.97M
52W Range
$0.84 - $2.01
Target Price
$3.10
GERN stock price is $0.99 (+0.05% on the day), giving Geron Corporation a market cap of $637.99M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
GERN Stock Overview
- Price
- $0.99
- Previous close
- $0.99
- Open
- $0.99
- Market cap
- $637.99M
- 52-week range
- $0.84 - $2.01
- 1-year price target
- $3.10
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- Nasdaq
- MarketXLS Rank
- 43
About Geron Corporation
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GERN | $0.99 | +0.1% | 2.97M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |